Original Article
VOLUME: 40 | ISSUE: 1 | Mar 15, 2024 | PAGE: (32 - 36) | DOI: 10.24911/BioMedica/5-1148
Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study
Authors: Muhammad Ilyas , Ghulam Dastgir Khan , Ghazala Rubi , Hurtamina Khan , Adeel Niaz , Waqas Javaid ,
Article Info
Authors
Muhammad Ilyas
Assoc Professor and Head, Dept of ENT Unit-II, Ameer ud Din Medical College, Postgraduate Medical Institute, Lahore, Pakistan.
Ghulam Dastgir Khan
Associate Professor, Department of ENT, Sharif Medical College, Lahore, Pakistan.
Ghazala Rubi
Director Research Lab & Head of Molecular Genetics Pathology at Post Graduate Medical Institute, Lahore, Pakistan.
Hurtamina Khan
Associate Professor, Department of ENT, Jinnah Sindh Medical University, Karachi, Pakistan.
Adeel Niaz
Assistant Professor, Department of ENT, Ameer ud Din Medical college, Post Graduate Medical Institute, Lahore, Pakistan.
Waqas Javaid
Assistant Professor of ENT Fatima Jinnah Medical University/Ganga Ram hospital, Lahore, Pakistan.
Publication History
Received: January 02, 2024
Revised: February 12, 2024
Accepted: March 10, 2024
Published: March 15, 2024
Abstract
Background and Objective: A concerning increase in occurrences of COVID-19-associated mucormycosis (CAM), has been reported worldwide in people who are coping with COVID-19 disease. Despite this apparent correlation, the exact association is yet unknown. To ascertain the degree to which mucormycosis and coronavirus illnesses are associated, this study was conducted to analyze the relationship between COVID-19 and mucormycosis infection.
Methods: This observational study examined 35 individuals who had been diagnosed with mucormycosis at Lahore General Hospital, Lahore, Pakistan. The relationship between mucormycosis and coronavirus disease was determined by analyzing the patient’s demographics, gender, COVID-19 status, and co-morbidities.
Results: The mean age of the enrolled patients was 49.40 ± 13.511 years with the majority (54.3%) being male. A total of 25.7% had confirmed COVID-19-positive disease. Notably, diabetes mellitus (DM) was the predominant co-morbidity in a significant proportion of patients (74.3%), followed by comorbidity of DM with chronic kidney disease (11.4%), chronic liver disease (8.6%), and hypertension (5.7%). The presence of co-morbidities and COVID-19 were significantly correlated (p < 0.05) in mucormycosis patients, whereas age and gender had no significant association (p > 0.05).
Conclusion: In conclusion, mucormycosis could be an additional aspect of the pandemic’s spectrum. The data from our study supports this claim since a significant percentage of the patients with mucormycosis had a positive COVID-19 disease concomitantly.
Keywords: COVID-19, Mucormycosis, Diabetes Mellitus, Pandemic, Comorbidities
Pubmed Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica. 2024; 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148
Web Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. https://biomedicapk.com/articles/online_first/1148 [Access: April 29, 2024]. doi:10.24911/BioMedica/5-1148
AMA (American Medical Association) Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica. 2024; 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148
Vancouver/ICMJE Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica. (2024), [cited April 29, 2024]; 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148
Harvard Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid (2024) Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica, 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148
Chicago Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. "Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study." 15 (2024), 32-36. doi:10.24911/BioMedica/5-1148
MLA (The Modern Language Association) Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. "Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study." 15.March 2024 (2024), 32-36. Print. doi:10.24911/BioMedica/5-1148
APA (American Psychological Association) Style
Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid (2024) Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. , 15 (March 2024), 32-36. doi:10.24911/BioMedica/5-1148